Geselecteerde datamodellen

U moet ingelogd zijn om meerdere datamodellen te selecteren en die te downloaden of te analyseren.

71 Zoekresultaten.
Relevantie Beoordeling Nieuwe eerst Oude eerst

Eligibility Carcinoma, Non-Small Cell Lung NCT02098954

- 15-01-19 - 1 Formulier, 2 Itemgroepen, 10 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
Erlotinib Combined With Chemotherapy in TKI Resistant Non-Small Cell Lung Cancers; ODM derived from: https://clinicaltrials.gov/show/NCT02098954

Eligibility Carcinoma, Non Small Cell Lung NCT02135211

- 15-01-19 - 1 Formulier, 1 Itemgroep, 11 Data-elementen, 1 Taal
Itemgroep: Criteria
Healthy Directions After Lung Surgery Pilot; ODM derived from: https://clinicaltrials.gov/show/NCT02135211

Eligibility Chemotherapeutic Agent Toxicity NCT01097317

- 27-11-17 - 1 Formulier, 1 Itemgroep, 12 Data-elementen, 1 Taal
Itemgroep: Criteria
First-Line Chemotherapy With or Without Neuromuscular Electrical Stimulation in Treating Patients With Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01097317

Eligibility Carcinoma, Non-Small-Cell Lung NCT01022671

- 17-11-17 - 1 Formulier, 2 Itemgroepen, 17 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
Study of Camtobell Inj (Belotecan) on Weekly Schedule in Non-small Cell Lung Cancer (NSCLC) Patients Previously Treated With Chemotherapy; ODM derived from: https://clinicaltrials.gov/show/NCT01022671

Eligibility Carcinoma, Non-Small-Cell Lung NCT00993499

- 17-11-17 - 1 Formulier, 2 Itemgroepen, 20 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
Trial of Continuous Once Daily Oral Treatment Using BIBW 2992 (Afatinib) Plus Sirolimus (Rapamune®) in Patients With Non-small Cell Lung Cancer Harbouring an EGFR Mutation and/or Disease Progression Following Prior Erlotinib or Gefitinib; ODM derived from: https://clinicaltrials.gov/show/NCT00993499

Eligibility Carcinoma, Non-Small-Cell Lung NCT00979576

- 17-11-17 - 1 Formulier, 2 Itemgroepen, 48 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
BIBF 1120 in Combination With Pemetrexed in Advanced Non Small Cell Lung Cancer (NSCLC); ODM derived from: https://clinicaltrials.gov/show/NCT00979576

Eligibility Carcinoma, Non-Small-Cell Lung NCT00835471

- 16-11-17 - 1 Formulier, 2 Itemgroepen, 20 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
2nd Line Erlotinib Treatment With (Out) Chemotherapy of Advanced Non Small Cell Lung Cancer (NSCLC); ODM derived from: https://clinicaltrials.gov/show/NCT00835471

Eligibility Carcinoma, Non-Small-Cell Lung NCT00824408

- 16-11-17 - 1 Formulier, 2 Itemgroepen, 30 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
Trial of BI 6727 (Volasertib) Monotherapy and BI 6727 in Combination With Pemetrexed Compared to Pemetrexed Monotherapy in Advanced NSCLC; ODM derived from: https://clinicaltrials.gov/show/NCT00824408

Eligibility Carcinoma, Non-Small-Cell Lung NCT00806819

- 15-11-17 - 1 Formulier, 2 Itemgroepen, 26 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC; ODM derived from: https://clinicaltrials.gov/show/NCT00806819

Eligibility Carcinoma, Non-Small-Cell Lung NCT00791336

- 15-11-17 - 1 Formulier, 2 Itemgroepen, 21 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
Study to Evaluate Using Nelfinavir With Chemoradiation for Non-small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00791336

Eligibility Carcinoma, Non-Small-Cell Lung NCT00730925

- 15-11-17 - 1 Formulier, 2 Itemgroepen, 29 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
Single-arm Trial of BIBW 2992 (Afatinib) in Demographically and Genotypically Selected NSCLC Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00730925

Eligibility Carcinoma, Non-Small-Cell Lung NCT00690963

- 14-11-17 - 1 Formulier, 2 Itemgroepen, 18 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
Individual Boosting in Non-Small Cell Lung Cancer Using Hypofractionation, Intensity-modulated Radiation Therapy and Respiratory Gating; ODM derived from: https://clinicaltrials.gov/show/NCT00690963

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial